Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
XPER
|
Mark Kokes
Chief Licensing Officer, Media |
SELL
Payment of exercise price or tax liability
|
Direct | 6,259 Reduced 2.6% |
$106,653
$17.04 p/Share
|
Nov 01
2025 |
|
AN
|
Jeff Parent
COO |
SELL
Payment of exercise price or tax liability
|
Direct | 114 Reduced 9.04% |
$22,785
$199.87 p/Share
|
Nov 01
2025 |
|
AN
|
Jeff Parent
COO |
BUY
Exercise of conversion of derivative security
|
Direct | 288 Added 18.59% |
-
|
Nov 01
2025 |
|
SYK
|
Preston Wendell Wells
VP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 404 Reduced 5.56% |
$143,920
$356.24 p/Share
|
Nov 01
2025 |
|
NVCR
|
Mukund Paravasthu
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 168 Reduced 0.2% |
$2,152
$12.81 p/Share
|
Nov 01
2025 |
|
ST
|
Nicolas Bardot
EVP, Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct | 15,709 Added 50.0% |
-
|
Nov 01
2025 |
|
EBAY
|
Mohak Shroff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 277 Added 1.14% |
-
|
Nov 01
2025 |
|
ABC
|
Dennis M Nally
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 0.77% |
$35,132
$337.81 p/Share
|
Nov 01
2025 |
|
AFRM
|
Libor Michalek
President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,186 Reduced 0.59% |
$85,249
$71.88 p/Share
|
Nov 01
2025 |
|
AFRM
|
Libor Michalek
President |
BUY
Exercise of conversion of derivative security
|
Direct | 2,335 Added 1.16% |
-
|
Nov 01
2025 |
|
AFRM
|
Michael Linford
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 983 Reduced 1.93% |
$70,658
$71.88 p/Share
|
Nov 01
2025 |
|
AFRM
|
Michael Linford
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,335 Added 4.38% |
-
|
Nov 01
2025 |
|
CACI
|
Jeffrey D Maclauchlan
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,029 Reduced 28.84% |
$1,703,055
$562.25 p/Share
|
Nov 01
2025 |
|
CACI
|
Jeffrey D Maclauchlan
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,173 Added 38.26% |
-
|
Nov 01
2025 |
|
AFRM
|
Katherine Adkins
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 772 Reduced 0.62% |
$55,491
$71.88 p/Share
|
Nov 01
2025 |
|
AFRM
|
Katherine Adkins
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,705 Added 1.34% |
-
|
Nov 01
2025 |
|
ABC
|
Lauren M Tyler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 89 Added 2.82% |
$30,065
$337.81 p/Share
|
Nov 01
2025 |
|
EBAY
|
Zane Rowe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 333 Added 3.53% |
-
|
Nov 01
2025 |
|
FIVE
|
Graham Poliner
CSBIAO |
SELL
Payment of exercise price or tax liability
|
Direct | 251 Reduced 1.27% |
$39,474
$157.27 p/Share
|
Nov 01
2025 |
|
ABC
|
Werner Baumann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 108 Added 3.34% |
$36,483
$337.81 p/Share
|
Nov 01
2025 |
|
GTX
|
Joanne Lau
VP, CAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,023 Reduced 0.85% |
$17,329
$16.94 p/Share
|
Nov 01
2025 |
|
EBAY
|
Perry M Traquina
Director |
BUY
Grant, award, or other acquisition
|
Direct | 379 Added 0.44% |
-
|
Nov 01
2025 |
|
GTX
|
Mark D. Rollinger
SVP, GC & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 17,710 Added 50.0% |
-
|
Nov 01
2025 |
|
FELE
|
Gregg C Sengstack
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 145 Reduced 0.11% |
$13,741
$94.77 p/Share
|
Nov 01
2025 |
|
FELE
|
Gregg C Sengstack
Director |
BUY
Grant, award, or other acquisition
|
Direct | 366 Added 0.28% |
$34,685
$94.77 p/Share
|
Nov 01
2025 |
|
EBAY
|
Logan Green
Director |
BUY
Grant, award, or other acquisition
|
Direct | 293 Added 0.59% |
-
|
Nov 01
2025 |
|
NVCR
|
Frank X Leonard
EVP, Pres., Novocure Oncology |
SELL
Payment of exercise price or tax liability
|
Direct | 966 Reduced 0.28% |
$12,374
$12.81 p/Share
|
Nov 01
2025 |
|
LE
|
Andrew J. Mc Lean
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 27,174 Reduced 18.2% |
$427,718
$15.74 p/Share
|
Nov 01
2025 |
|
LE
|
Andrew J. Mc Lean
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 57,817 Added 27.92% |
-
|
Nov 01
2025 |
|
VNRX
|
Gael Forterre
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,753 Reduced 1.13% |
$753
$0.43 p/Share
|
Nov 01
2025 |
|
NCR
|
Darren Wilson
EVP & Pres, Retail & Payments |
SELL
Payment of exercise price or tax liability
|
Direct | 9,194 Reduced 42.4% |
$104,903
$11.41 p/Share
|
Nov 01
2025 |
|
NCR
|
Darren Wilson
EVP & Pres, Retail & Payments |
BUY
Exercise of conversion of derivative security
|
Direct | 19,561 Added 47.42% |
-
|
Nov 01
2025 |
|
VNRX
|
Salvatore Thomas Butera
CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct | 4,648 Reduced 1.42% |
$1,998
$0.43 p/Share
|
Nov 01
2025 |
|
VNRX
|
Rodney Gerard Rootsaert
Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 3,197 Reduced 2.28% |
$1,374
$0.43 p/Share
|
Nov 01
2025 |
|
VNRX
|
Nicholas Plummer
GC - Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct | 5,647 Reduced 2.83% |
$2,428
$0.43 p/Share
|
Nov 01
2025 |
|
SPGI
|
Christina Twomey
Chief Communications Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 65 Reduced 7.25% |
$31,668
$487.21 p/Share
|
Nov 01
2025 |
|
SPGI
|
Christina Twomey
Chief Communications Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 188 Added 17.34% |
$91,595
$487.21 p/Share
|
Nov 01
2025 |
|
VNRX
|
Andrew Retter
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,588 Reduced 3.04% |
$1,972
$0.43 p/Share
|
Nov 01
2025 |
|
DH
|
Jason Ronald Krantz |
SELL
Payment of exercise price or tax liability
|
Direct | 18,796 Reduced 1.74% |
$52,064
$2.77 p/Share
|
Nov 01
2025 |
|
CDNA
|
Jeffrey Adam Novack
Secretary and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 2,872 Reduced 2.54% |
$42,419
$14.77 p/Share
|
Nov 01
2025 |
|
DH
|
Casey Heller
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,244 Reduced 0.12% |
$3,445
$2.77 p/Share
|
Nov 01
2025 |
|
GOCO
|
Brendan Richard Shanahan
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 12,725 Reduced 5.09% |
$50,391
$3.96 p/Share
|
Nov 01
2025 |
|
FRD
|
Gaurav Chhibbar
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 50,000 Added 50.0% |
-
|
Nov 01
2025 |
|
LH
|
Megan D. Bailey
EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct | 370 Added 8.93% |
-
|
Nov 01
2025 |
|
LH
|
Akinbolade Oyegunwa
EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct | 370 Added 8.8% |
-
|
Nov 01
2025 |
|
CAL
|
Ward M Klein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,316 Added 2.23% |
$24,989
$10.79 p/Share
|
Nov 01
2025 |
|
CAL
|
Molly Langenstein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,316 Added 10.77% |
$24,989
$10.79 p/Share
|
Nov 01
2025 |
|
TBI
|
Carl Schweihs
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,130 Reduced 0.65% |
$5,356
$4.74 p/Share
|
Nov 01
2025 |
|
HUM
|
Gordon Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 765 Added 50.0% |
-
|
Nov 01
2025 |
|
MSBI
|
Eric Lemke
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 472 Reduced 1.64% |
$6,910
$14.64 p/Share
|
Nov 01
2025 |